Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients

Phase 2

Terminated

Conditions: Acute Coronary Syndrome

Interventions: Drug: Apixaban
Other: Placebo

First Posted Date: 2009-02-27

Last Posted Date: 2013-08-29

Lead Sponsor: Pfizer

Target Recruit Count: 151

Registration Number: NCT00852397

Locations: 🇯🇵
Pfizer Investigational Site, Osaka, Japan

Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy

Phase 4

Completed

Conditions: Rheumatoid Arthritis

First Posted Date: 2009-02-20

Last Posted Date: 2016-01-18

Lead Sponsor: Pfizer

Target Recruit Count: 429

Registration Number: NCT00848354

Locations: 🇦🇷
Consultorios Especializados en Investigaciones Medicas, Capital Federal, Buenos Aires, Argentina
🇦🇷
CER San Juan, San Juan, Provinica de San Juan, Argentina
🇦🇷
Instituto CAICI, Rosario, Santa Fe, Argentina

and more 30 locations

A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate

Phase 3

Completed

Conditions: Arthritis, Rheumatoid

Interventions: Drug: Placebo
Drug: CP-690,550

First Posted Date: 2009-02-19

Last Posted Date: 2024-05-16

Lead Sponsor: Pfizer

Target Recruit Count: 800

Registration Number: NCT00847613

Locations: 🇺🇦
Pfizer Investigational Site, Vinnitsa, Ukraine

Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration

Completed

Conditions: Macular Degeneration

Interventions: Drug: Pegaptanib sodium

First Posted Date: 2009-02-18

Last Posted Date: 2015-10-02

Lead Sponsor: Pfizer

Target Recruit Count: 3538

Registration Number: NCT00845273

A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine

Phase 1

Completed

Conditions: Malaria

Interventions: Drug: Fixed combination of Azithromycin and Chloroquine
Drug: Azithromycin and Chloroquine

First Posted Date: 2009-02-16

Last Posted Date: 2009-04-21

Lead Sponsor: Pfizer

Target Recruit Count: 40

Registration Number: NCT00844207

Locations: 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States

Observational Study Of Donepezil In Routine Clinical Practice

Terminated

Conditions: Alzheimer's Disease

Interventions: Other: donepezil

First Posted Date: 2009-02-13

Last Posted Date: 2014-03-13

Lead Sponsor: Pfizer

Target Recruit Count: 370

Registration Number: NCT00843115

Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer

Phase 1

Completed

Conditions: Advanced Gastric Cancer
Stomach Neoplasms

Interventions: Drug: axitinib
Drug: capecitabine
Drug: cisplatin

First Posted Date: 2009-02-12

Last Posted Date: 2013-11-27

Lead Sponsor: Pfizer

Target Recruit Count: 22

Registration Number: NCT00842244

Locations: 🇰🇷
Pfizer Investigational Site, Seoul, Korea, Republic of

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Phase 3

Completed

Conditions: Encephalitis, Tick-Borne

Interventions: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

First Posted Date: 2009-02-10

Last Posted Date: 2024-01-19

Lead Sponsor: Pfizer

Target Recruit Count: 302

Registration Number: NCT00840801

Locations: 🇦🇹
Unterer Graben 2, Eferding, Upper Austria, Austria
🇦🇹
Grieskirchnerstr.17, Wels, Upper Austria, Austria
🇨🇿
Private surgery of General Practitioner for children and juveniles, Pardubice, Czechia

and more 2 locations

Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery

Phase 2

Completed

Conditions: Cardiac Surgery Subjects
Subjects Undergoing CABG and/or Cardiac Valve Replacement

Interventions: Drug: Placebo
Drug: sitaxsentan (Thelin)

First Posted Date: 2009-02-06

Last Posted Date: 2022-09-08

Lead Sponsor: Pfizer

Target Recruit Count: 29

Registration Number: NCT00838383

Locations: 🇺🇸
University of Pennsylvania,, Philadelphia, Pennsylvania, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸
The Chattanooga Heart Institute, Chattanooga, Tennessee, United States

A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis.

Phase 1

Completed

Conditions: Rheumatoid Arthritis
Healthy Volunteers

Interventions: Drug: CE-224,535
Drug: CE 224,535

First Posted Date: 2009-02-06

Last Posted Date: 2009-10-14

Lead Sponsor: Pfizer

Target Recruit Count: 11

Registration Number: NCT00838058

Locations: 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy